In mid-December 2024, social media users began circulating a claim that millions of bottles of the cleaning agent Fabuloso ...

Pseudomonas may also be found on the skin of some people and not necessarily cause infection. This is known as colonisation. For these people, a risk assessment is carried out. Treatment may be ...

Even after four weeks of exposure, a usual treatment duration for Pseudomonas infections, we could not find resistance against our new random peptide, but against other antimicrobials." ...

Armata Pharmaceuticals (ARMP) announced “encouraging” topline results from its Phase 2 trial evaluating AP-PA02, a novel, inhaled multi-phage therapeutic for the treatment of chronic pulmonary ...

Fonseca Biosciences ("Fonseca") announced today an agreement with MerLion Pharmaceuticals GmbH granting Fonseca the exclusive ...

Iron-chelating pyoverdines from environmental Pseudomonas spp. show promising antibacterial activity against key human pathogens through the induction of iron starvation, while associated toxicity for ...

Coverage of Key Players Armata Pharmaceuticals, Aridis Pharmaceuticals, Gilead Sciences, Respirion Pharmaceuticals and BiomXDublin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The "Chronic Pseudomonas ...

The trust said an additional chemical treatment system was installed on the pipework system and sections of pipework were replaced. It said a further two positive samples of pseudomonas were ...